瑞马佐拉姆可以安全地用于心脏吸管吗? :一个案例报告
Hyun Joo Heo1, Geonbo Kim, Yu Yil Kim
1Department of Anesthesiology and Pain Medicine, Presbyterian Medical Center, Jeonju, Jeollabuk-Do, Korea.
Medicine
|August 11, 2023
概括
雷米马佐拉姆可能会导致严重的血液动力学不稳定性,在接受心脏吸管麻醉的患者. 这种 benzodiazepine,用于麻醉诱导,导致低血压和心肌梗塞在一个案例研究.
科学领域:
- 麻醉学 麻醉学
- 心血管麻醉心血管麻醉
背景情况:
- 雷米马佐拉姆是一种用于麻醉诱导和维持的二类药物.
- 众所周知,它可以提供血液动力学稳定性.
- 它对心脏吸管患者的影响尚未得到充分证实.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
22
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
22
Pericarditis IV: Nursing Management
20
Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.
20
Pericarditis III: Medical Management
15
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
15


